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IMPORTANCE Ameta-analysis of outcomes during the 6months after intensive care unit
(ICU) discharge indicate a prevalence for clinically important posttraumatic stress disorder
(PTSD) symptoms of 25%.
OBJECTIVE Todeterminewhether a nurse-led preventive, complex psychological intervention,
initiated in the ICU, reduces patient-reportedPTSD symptomseverity at 6months.
DESIGN, SETTING, AND PARTICIPANTS Amulticenter, parallel-group, cluster-randomized clinical
trial with integrated economic and process evaluations conducted in 24 ICUs in the United
Kingdom. Participants were critically ill patients who regainedmental capacity following receipt
of level 3 (intensive) care. A total of 2961 eligible patients were identified from September 2015
to January 2017. A total of 2048were approached for participation in the ICU, of which 1458
provided informed consent. Follow-upwas completed December 2017.
INTERVENTIONS Twenty four ICUs were randomized 1:1 to the intervention or control group.
Intervention ICUs (n = 12; 669 participants) delivered usual care during a baseline period
followed by an intervention period. The preventive, complex psychological intervention
comprised promotion of a therapeutic ICU environment plus 3 stress support sessions and a
relaxation and recovery program delivered by trained ICU nurses to high-risk (acutely
stressed) patients. Control ICUs (n = 12; 789 participants) delivered usual care in both
baseline and intervention periods.
MAIN OUTCOMES ANDMEASURES The primary clinical outcomewas PTSD symptom severity
among survivors at 6months measured using the PTSD Symptom Scale–Self-Report
questionnaire (score range, 0-51, with higher scores indicating greater symptom severity; the
minimal clinically important difference was considered to be 4.2 points).
RESULTS Among 1458 enrolled patients (mean [SD] age, 58 [16] years; 599women [41%]),
1353 (93%) completed the study and were included in the final analysis. At 6months, the
mean PTSD Symptom Scale–Self-Report questionnaire score in intervention ICUs was 11.8
(baseline period) compared with 11.5 (intervention period) (difference, −0.40 [95% CI, −2.46
to 1.67]) and in control ICUs, 10.1 (baseline period) compared with 10.2 (intervention period)
(difference, 0.06 [95% CI, −1.74 to 1.85]) between periods. There was no significant
difference in PTSD symptom severity at 6months (treatment effect estimate [difference in
differences] of −0.03 [95% CI, −2.58 to 2.52]; P = .98).
CONCLUSIONSANDRELEVANCE Amongcritically ill patients in the ICU, anurse-ledpreventive,
complexpsychological interventiondidnot significantly reducepatient-reportedPTSDsymptom
severity at6months. These findingsdonot support theuseof this psychological intervention.
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Among patients admitted to the intensive care unit(ICU), a meta-analysis of outcomes for survivors,during the first 6 months after ICU discharge, indi-
cated a pooled prevalence for clinically important posttrau-
matic stress disorder (PTSD) symptoms of 25%.1 Acute
stress while in the ICU2,3 and early memories of frightening
ICU experiences (eg, hallucinations, paranoid delusions,
and nightmares)1 have been identified as independent risk
factors for longer-term psychological morbidity, including
PTSD symptom severity. Evidence suggests that addressing
these risk factors early, commencing while in the ICU, might
prevent longer-term consequences4 and that addressing
such factors after discharge may be too late.5 Research on
ICU patients with trauma indicated that fewer experienced
PTSD symptoms if they were seen by clinical psychologists
while in the ICU.6
Cognitive behavioral therapy (CBT) techniques have been
found to be effective in reducing symptoms of stress in pa-
tients with mental or physical illness,7 mitigating hallucina-
tions andparanoiddelusions inmentalhealth settings,8 and in
reducing PTSD symptoms.9 Studies have evaluated CBT tech-
niques as effective when delivered by nonexperts (including
nurses) to patients in physical andmental health settings.10,11
A UK National Institute for Health and Care Excellence
evidence update9 on PTSD suggested that an early (immedi-
ate), brief (3 sessions), trauma-focused CBT intervention
“may reduce the development of subsequent trauma symp-
toms more than no such intervention” and called for further
research. It was hypothesized that a preventive, complex
psychological intervention initiated in the ICU would
reduce development of patient-reported PTSD symptom
severity at 6 months. Acknowledging that few National
Health Service ICUs have regular access to psychologists
and evidence indicating that nonexperts can be trained to
deliver effective psychological interventions, it was decided
to train ICU-selected nurses to deliver a preventive, com-
plex psychological intervention. Following intervention fea-
sibility testing and refinement,12 its clinical and cost-
effectiveness were evaluated in a cluster-randomized
clinical trial.13
Methods
Study Design andOversight
The South Central–Oxford B research ethics committee ap-
provedtheprotocol,which isavailable inSupplement 1.Allpar-
ticipants provided written informed consent.
The POPPI (Psychological Outcomes Following a Nurse-
Led Preventive Psychological Intervention for Critically Ill
Patients) trial was a multicenter, parallel-group, cluster-
randomized clinical trial, with integrated economic and pro-
cess evaluations.13 Randomization was at the ICU (cluster)
level because it would not be possible to restrict parts of the
preventive, complex psychological intervention to indi-
vidual patients.
The UK National Institute for Health Research convened
an independently chaired trial steering committee and inde-
pendent data monitoring and ethics committee. The Inten-
sive Care National Audit & Research Centre (ICNARC) Clinical
Trials Unit managed the trial.
Sites and Patients
The trial was conducted in 24 adult general ICUs. ICUs were
eligible if theywereactiveparticipants in the ICNARCCaseMix
Programme, able to adhere to randomization and deliver the
intervention, andcoulddemonstratepotential to recruit to tar-
get. Stand-alone high-dependency units and specialist criti-
cal care units were excluded, alongwith ICUs offering formal
psychological support (ICU diary use was permitted as not
deemedanearly intervention).Adultpatients (≥18yearsofage)
were eligible if they met the inclusion criteria, which in-
cluded at least 48 hours in the ICU, receipt of level 3 (inten-
sive) care (eg, advanced respiratory monitoring and support
or monitoring and support for ≥2 organ systems) during that
time, between a score of +1 and−1 on theRichmondAgitation
Sedation Scale,14 Glasgow Coma Scale score of 15,15 English-
speaking, and able to communicate orally. Patients were ap-
proached to participate while in the ICU. State anxiety, using
the State Trait Anxiety Inventory (6-item version, STAI-6),16
and health-related quality of life (HrQoL) using a visual ana-
logue scale, were assessed at time of consent (see eMethods
in Supplement 2).
Randomization and Treatment Groups
Using a stepped rollout, ICUs were allocated geographically,
into 3 steps of 8, opening at 2-month intervals. ICUs in each
step were randomized 1:1 to the intervention (n = 4) or con-
trol (n = 4) group in the secondmonth of the baseline period.
Allocationwasconductedusinga restricted randomizationap-
proach to ensure balance of hospital teaching status and size
of the ICU.17 The recruitment periodwas 17months (eFigure 1
in Supplement 2).
Intervention
The preventive, complex psychological intervention was de-
signed to alleviate acute stress and memories of frightening
ICU experiences such as hallucinations, paranoid delusions,
Key Points
Question What is the effect of a nurse-led preventive, complex
psychological intervention delivered to critically ill patients and
initiated in the intensive care unit on posttraumatic stress disorder
(PTSD) symptom severity?
Findings In this cluster-randomized clinical trial, involving 1458
patients, there was no significant difference in patient-reported
PTSD symptom severity at 6months (adjusted difference of −0.03
on the PTSD Symptom Scale; score range, 0-51, with higher scores
indicating greater symptom severity; the minimal clinically
important difference was considered to be 4.2 points).
Meaning A nurse-led preventive, complex psychological
intervention delivered to critically ill patients and initiated in the
intensive care unit did not significantly reduce patient-reported
PTSD symptom severity at 6months.
Research Original Investigation Effect of a Nurse-Led Preventive Psychological Intervention on Post-ICU PTSD Symptoms
666 JAMA February 19, 2019 Volume 321, Number 7 (Reprinted) jama.com
© 2019 American Medical Association. All rights reserved.
Downloaded From: https://jamanetwork.com/ by a Queen's University Belfast User  on 09/09/2019
and nightmares. It comprised promotion of a therapeutic en-
vironment (via online training) and stress support for high-
risk patients delivered by trained ICU nurses. Building on ex-
istingevidenceanddrawingon theoriesand techniquesofCBT
for reducing stress, trauma, hallucinations, and paranoid de-
lusionsadaptedforusewith ICUpatients, thecontentandtrain-
ing courses and materials for delivery of the complex inter-
vention were informed, developed, and refined by the lead
adult ICU health psychologist (D.M.W.), supported by 2 se-
niorpsychologists (C.R.B.andJ.Weinman),withoversight from
an expert psychology advisory group, independently chaired
by a senior clinical psychologist (Daniel Freeman, PhD,
DClinPsy,University ofOxford,Oxford,UnitedKingdom).The
expert psychology advisory group also included expertise in
clinical education, ICU nursing, and lived experience from 3
former ICU patients.
Intervention ICUs delivered usual care during the base-
line period (months 1-5) followed by a 1-month transition pe-
riod (month6).At the start of the transitionperiod, all patient-
facing ICUstaffwereprovidedaccess to theonline trainingand
ICU nurses, self-selected by ICUs, attended a 3-day training
course (ledbyD.M.W.) on thecontent anddeliveryof the stress
support. Following practical experience in their ICUs, at the
end of the transition period, the trained ICU nurses were as-
sessed for competency.
During the intervention period (month 7 onwards), ICU
staff were encouraged to engage in activities to promote a
therapeutic environment. In parallel, patients who had con-
sented were assessed for acute stress using the Intensive
care Psychological Assessment Tool (IPAT).18 Patients scor-
ing 7 points or more (high risk) were offered 3 one-to-one
stress support sessions. These incorporated CBT approaches
such as emotional expression, normalization, psychoeduca-
tion, cognitive reappraisal, and “homework” tasks. Sessions
were intended to last approximately 30 minutes each, be
delivered by the same trained ICU nurse, and be completed
within a week in hospital. Patients were reassessed with the
STAI-6 after completion of the third session. Between ses-
sions, patients could use the relaxation and recovery pro-
gram (incorporating coping strategies, such as relaxing
music and meditation exercises, and patient recovery sto-
ries) on a tablet computer. A DVD with similar content and a
self-help booklet, with a codesigned personal action plan,
were provided to patients for use after hospital discharge
(eFigure 2 in Supplement 2).
Debriefing and support were provided to the trained ICU
nurses (eMethods in Supplement 2). An independent, inte-
gratedprocessevaluationwasconducted (eMethods inSupple-
ment 2). Control ICUs delivered usual care throughout.
OutcomeMeasures
Theprimary clinical effectivenessoutcomewasmeanpatient-
reported PTSD symptom severity, measured using the PTSD
SymptomScale–Self-Report (PSS-SR) questionnaire,19 among
survivors at 6 months. Scores on the PSS-SR questionnaire
range from0to51,withhigher scores indicatinggreater symp-
tomseverity (seeeTables 1 and2andeFigure3 inSupplement2
forpriorpsychometricevaluation).Toourknowledge,nostud-
ies have been conducted to establish aminimal clinically im-
portant difference; a value of 4.2 pointswas established from
feasibility studies and baseline trial data (see the Statistical
Analysis section). The cost-effectiveness analysis reported in-
cremental costs, including those of adopting the interven-
tion, quality-adjusted life-years, and incremental net mon-
etary benefit of the intervention at 6 months (eTables 3 to 4
in Supplement 2).
Secondary outcomes were days alive and free from seda-
tion to day 30; duration of ICU stay; and, among survivors at
6months,PSS-SRquestionnaire threshold forpredictionofcur-
rent or future PTSD (>18 points),20 anxiety and depression
(measured using the Hospital Anxiety and Depression Scale
[HADS])21, andHrQoL (measured using the European Quality
of Life–5 Dimensions 5-level questionnaire).22 HADS com-
prises 2 subscales (anxiety and depression); subscale scores
range from0 to 21,with higher scores indicatingworse sever-
ity and a value of 8 points considered the threshold for likely
anxiety or depression. TheEuropeanQuality of Life–5Dimen-
sions 5-level questionnaire utility scale ranges from−0.285 to
1, with lower scores indicating worse HrQoL, anchored at 0
(death) and 1 (perfecthealth).23 Fordetails of all outcomes, see
eMethods in Supplement 2.
Statistical Analysis
The original design was for 24 ICUs to recruit for 11 months,
consisting of a 5-month baseline, a 1-month transition, and
a 5-month intervention period. The proposed design was
reviewed following completion of feasibility studies,12
retaining 90% power with a 5% type I error rate, and using
the method of Hussey and Hughes24 for a general, multipe-
riod, cluster-randomized clinical trial, under the following
assumptions based on data from the feasibility studies: a
mean (SD) PSS-SR score of 6 (7.5) points; an estimated intra-
cluster correlation of 0.138, based on an assumption of 0.5
for the between-ICU coefficient of variation; a detectable
treatment effect of a reduction of 2.9 points on the PSS-SR
questionnaire (based on a difference equivalent to the reli-
able change index for the PSS-SR score of 8.6 points calcu-
lated from feasibility study data using the method of Jacob-
son and Truax25 being observed among 40% of patients
assessed as acutely stressed and receiving stress support
sessions and assuming 16% declined the intervention); and
an estimated harmonic mean of the number of patients
completing follow-up of 22 per ICU during each 5-month
period (anticipating mortality of 10% and loss to follow-up
of 20% at 6 months).
The expected total number of patients to be recruitedwas
1914. The pretrial power calculation was updated during the
baseline period. Using available data, the mean (SD) PSS-SR
score in the control group at 6 months was estimated as 10.3
(10.8) andan intracluster correlationof0.087.Basedonamini-
mal clinically important differenceof 4.2points (retaining the
same effect size as amultiple of the SD) and a harmonicmean
of 16.5 patients per ICU completing follow-up, a minimum of
1378 patients were needed to achieve 85% power. Recruit-
mentwas therefore extended in the interventionperiod to en-
sure this minimum sample size was achieved.
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Patients were analyzed according to their randomiza-
tion group and all analyses were prespecified.26 Multiple
imputation was used to address missing baseline, out-
come, and resource use data under the assumption that
responses were missing at random, conditional on the
observed data (eTable 5 in Supplement 2).27,28 The final
analyses were conducted using Stata/SE version 14.2
(StataCorp LP). Multiple imputation was performed in R ver-
sion 3.3.2 (The R Foundation for Statistical Computing;
Vienna, Austria). Sensitivity analyses assumed data were
(1) missing completely at random (using complete case data)
and (2) missing not at random (using expert elicitation)
(eMethods in Supplement 2). A P value of less than .05 indi-
cated statistical significance. All tests were 2-sided, with no
adjustment for multiple comparisons (secondary analyses
should therefore be interpreted as exploratory). Continuous
variables are reported as mean and SD or median and inter-
quartile range. Categorical variables are reported as propor-
tions. Patients recruited during the 1-month transition
period were excluded from the primary analysis.
We used generalized linear mixed models, with identity
link at the individual patient level (patients nested within
ICUs within treatment group/time periods), to compare dif-
ferences in the clinical primary outcome. The primary effect
estimate is the interaction between treatment group and
time period. Secondary analyses of the primary outcome
included estimation of the adherence-adjusted causal effect
of the stress support sessions. Analyses of secondary out-
comes were performed using generalized linear mixed
models with identity link for continuous and logit link for
binary outcomes. Analyses were adjusted for age, sex, race/
ethnicity (extracted from the patient record, coded using
standard National Health Service categories), deprivation,
preexisting anxiety/depression, planned admission follow-
ing elective surgery, and ICNARC Physiology Score.29 These
factors were selected a priori from a systematic review of
risk factors for PTSD after critical care.30
We conducted prespecified subgroup analyses by test-
ing interactions between the effect of the intervention and
age, sex, socioeconomic status,31 duration of delirium,
STAI-6 score16 (strongly correlated with IPAT18), surgical sta-
tus, predicted PSS-SR score,32 and degree of intervention
implementation (assessing dose, reach, and fidelity) in
intervention ICUs (eTable 6 in Supplement 2).
Results
Sites and Participants
All 24 ICUs opened to recruitment between September 2015
and January 2016. When compared with nonparticipating
ICUs, participating ICUs, while larger (beds and admissions),
were representative of teaching status and geography
(eTable 7 in Supplement 2). ICU diary use was reported at 9
intervention and 7 control ICUs. All 38 ICU nurses (3 from
each intervention ICU and 2 replacements) were trained and
assessed as competent.
Of 2961 potentially eligible patients, 2048 were
approached for informed consent and 1458 consented and
were recruited. Five withdrew consent, resulting in 1453
(100 recruited during the transition period were excluded
from the primary analyses, as planned). Similar eligibility
rates were observed across treatment group and time
period, but refusal of consent was more frequent at inter-
vention ICUs during the intervention period (eTable 8 in
Supplement 2). Figure 1 shows the CONSORT flow diagram33
of ICUs and patients through the trial. Participants were
well matched across treatment group and time period and
representative of the target ICU population (Table 1;
eTables 9-12 in Supplement 2).
Figure 1. Recruitment, Randomization, and Assessment
of Intensive Care Units (ICUs) and Patients
86 ICUs (clusters) assessed
for eligibility
62 ICUs excluded
32 Did not meet inclusion
criteria
22 Other reasonsa
8 Reserve ICUs
24 ICUs underwent
randomization 
12 ICUs randomized to intervention
12 Received intervention as
randomized
12 Included in the final analysis
Intervention period (month 7
onward): Intervention ICUs
delivered intervention
341 Patients recruited
1 Withdrew
Median, 25 (22-35) [18-47] 
per ICUb
340 Included in the final analysis
313 Consented to participate
in intervention
Transition period (month 6):
Intervention ICUs trained and 
began rollout of intervention
43 Patients recruited
1 Withdrew
Median, 4 (3-5) [0-6] per ICUb
42 Excluded from the final analysis
12 ICUs randomized to control
12 Received intervention as
randomized
12 Included in the final analysis
Baseline period (months 1-5):
Control ICUs delivered
usual care
285 Patients recruited 
1 Withdrew
Median, 23 (15-32) [11-38] 
per ICUb
284 Included in the final analysis
Intervention period (month 7
onward): Control ICUs
delivered usual care
446 Patients recruited
446 Included in the final analysis
Median, 37 (30-46) [10-72] 
per ICUb
Transition period (month 6):
Control ICUs delivered
usual care
58 Patients recruited
58 Excluded from the final analysis
Median, 5 (3-7) [0-9] per ICUb
Baseline period (months 1-5):
Intervention ICUs delivered
usual care
285 Patients recruited
1 Withdrew
1 Ineligible
283 Included in the final analysis
Median, 23 (16-29) [6-43] 
per ICUb
a Other reasons included poor performance in previous multicenter randomized
clinical trials, low evidence of ICU-wide enthusiasm and engagement, already
delivering early psychological support, and had planned to increase
psychological support during the trial period.
bMedian number (interquartile range) [range] of patients per ICU
are shown.
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Table 1. Characteristics of Patients in the POPPI Trial
Characteristic
Intervention ICUs, No. (%) Control ICUs, No. (%)
Baseline Period Intervention Period Baseline Period Intervention Period
No. of patients 283 340 284 446
Age, mean (SD), y 59.5 (16.0) 60.4 (15.0) 57.2 (16.2) 57.2 (15.6)
Sex
Male 168 (59.4) 187 (55.0) 179 (63.0) 268 (60.1)
Female 115 (40.6) 153 (45.0) 105 (37.0) 178 (39.9)
Race/ethnicitya
White 254 (89.8) 320 (94.1) 264 (93.0) 406 (91.0)
Mixed 0 (0.0) 1 (0.3) 1 (0.4) 2 (0.4)
Asian 4 (1.4) 1 (0.3) 3 (1.1) 6 (1.3)
Black 7 (2.5) 3 (0.9) 1 (0.4) 2 (0.4)
Other 8 (2.8) 2 (0.6) 0 (0.0) 4 (0.9)
Not stated 10 (3.5) 13 (3.8) 15 (5.3) 26 (5.8)
Quintile of Index of Multiple Deprivation 2015b
1 (Least deprived) 41 (14.5) 57 (16.9) 57 (20.1) 95 (21.3)
2 46 (16.3) 74 (21.9) 65 (22.9) 107 (24.0)
3 56 (19.8) 76 (22.5) 52 (18.3) 73 (16.4)
4 71 (25.1) 73 (21.6) 57 (20.1) 88 (19.8)
5 (Most deprived) 69 (24.4) 58 (17.2) 53 (18.7) 82 (18.4)
Documented preexisting anxiety/depressionc
Anxiety 3 (1.1) 12 (3.5) 4 (1.4) 9 (2.0)
Depression 19 (6.7) 32 (9.4) 19 (6.7) 33 (7.4)
Both 17 (6.0) 21 (6.2) 8 (2.8) 13 (2.9)
Elective surgical admission 17 (6.0) 20 (5.9) 24 (8.5) 37 (8.3)
Selected ICU admission diagnoses
Pneumonia 41 (14.5) 60 (17.6) 41 (14.4) 53 (11.9)
Trauma 26 (9.2) 26 (7.6) 23 (8.1) 30 (6.7)
Tumor or malignancy 14 (4.9) 22 (6.5) 23 (8.1) 32 (7.2)
Coma or seizures 11 (3.9) 15 (4.4) 21 (7.4) 37 (8.3)
ICNARC Physiology Score, mean (SD)d 21.1 (7.0) 21.0 (7.6) 21.2 (7.1) 21.4 (7.2)
APACHE II score, mean (SD)e 16.9 (6.5) 17.7 (6.4) 16.7 (5.8) 16.9 (6.2)
CAM-ICU–positive (delirium) duration in ICU
prior to consent, median (IQR), df
1 (0-2) 1 (0-2) 1 (0-3) 2 (1-3)
Assessed, No. 162 147 113 180
Time from ICU admission to consent,
median (IQR), d
7 (4-13) 9 (5-15) 7 (4-12) 8 (5-14)
Last NEWS prior to consent, mean (SD)g 3.2 (2.2) 2.8 (2.1) 3.1 (2.4) 2.8 (2.4)
STAI-6 score at time of consent, median (IQR)h 43 (33-57) 43 (30-55) 43 (30-53) 43 (33-50)
HrQoL (health thermometer score)
at time of consent, median (IQR)i
50 (35-70) 50 (30-70) 50 (40-70) 50 (40-70)
Abbreviations: APACHE, Acute Physiology and Chronic Health Evaluation;
CAM-ICU, Confusion Assessment Method for the Intensive Care Unit;
HrQoL, health-related quality of life; ICNARC, Intensive Care National Audit &
Research Centre; ICU, intensive care unit; IQR, interquartile range;
NEWS, National Early Warning Score; STAI-6, State Trait Anxiety Inventory.
a Information on race/ethnicity was collected as part of the CaseMix
Programme data set and was ascertained by review of medical records.
This field was collected to help describe the demographics of the patient
population and assess the representativeness of the sample.
bHigher values indicate greater deprivation.
c Documented preexisting anxiety/depression was ascertained by review of
medical records.
d Scores on the ICNARC Physiology Score range from0 to 100 (higher scores
indicate greater severity of illness). The score was calculated using physiology
readings from the first 24 hours following ICU admission.
e Scores on the APACHE II range from0 to 71 (higher scores indicate greater
severity of illness). The score was calculated using physiology readings from
the first 24 hours following ICU admission. A score of 17 on day 1 corresponds
to hospital mortality of around 18%.
f Not all patients were assessed for delirium prior to consent due to either being
ventilated and sedated (therefore not assessable) or the CAM-ICU not being
routinely used or documented in themedical records.
g Scores on the NEWS range from0 to 20 (higher scores indicate greater
severity of illness) and calculated from the last physiology readings
before consent.
h Scores on the 6-item STAI range from 20 to 80 (higher scores indicate greater
anxiety). Patients with a mean of 43 on the STAI-6 are above the cut point for
clinically significant symptoms of state (“at this moment”) anxiety. STAI-6 was
self-reported by patients at the time of consent.
i HrQoL scores range from0 (“the worst health you can imagine”) to 100 (“the
best health you can imagine”). HrQoL was self-reported by patients at the time
of consent.
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Delivery of the Intervention
By the end of the transition period, 971 of 1669 ICU staff
members had completed the online training, equating to a
median percentage of staff completing online training of
58% (interquartile range, 49% to 69%), with all ICUs achiev-
ing 80% (prespecified minimum target) by intervention
period month 3 (eFigure 4 in Supplement 2). Some ICUs
reinforced the online training with education. Initiatives
observed during the process evaluation included optimiza-
tion of sleep (through sleep packs, night-time lighting, and
clustering care); reduction of noise (through soft-close bins
and minimization of alarm and telephone noise); improved
patient orientation (through clocks, staff-patient interac-
tion, and whiteboards); and increased family involvement.
Some ICUs reported difficulties both in changing long-
standing practices and being restricted by the environmen-
tal limitations of the unit.
Of the 340 patients recruited at intervention ICUs during
the intervention period, 27 consented solely to questionnaire
follow-up, leaving 313who consented to assessmentwith the
IPAT and subsequent stress support sessions (where appli-
cable). All 313 patients were assessed with the IPAT and, of
these, 199 (63.6%) scored 7 or more and were eligible to re-
ceive the stress support sessions: 127 (63.8%) received 3, 33
(16.6%) received 2, 21 (10.6%) received 1, and 18 (9.0%) re-
ceived none (eFigure 5 in Supplement 2). Subsequent ses-
sionswere not delivered to 49 patients due to discharge from
hospital, with only 14 declining further sessions (eTable 13 in
Supplement 2). The first stress support sessionwas delivered
in the ICU for 72 patients (39.8%) (eTable 14 in Supple-
ment 2). Of the 181 patients who had at least 1 session, 170
(93.9%) accepted a tablet computer and, of these, 130 (76.5%)
reported using the relaxation and recovery program.Medical
interventions received in the ICUare summarized in eTable 15
in Supplement 2.
Nochanges inpsychological supportwereobservedat con-
trol ICUs during the trial.
Patient Follow-up
At follow-up, 978 patients (79.3%) who survived to 6months
completedquestionnaires (range, 78.4%to79.9%across treat-
ment group and time period), with no difference in response
rates or characteristics of responders between group or pe-
riod (eTables 16 and 17 in Supplement 2).
Effectiveness
There was no significant difference in the primary outcome.
At 6 months, the mean PSS-SR score among survivors re-
cruited in intervention ICUs was 11.8 in the baseline com-
paredwith 11.5 in the interventionperiod. In control ICUs, the
meanPSS-SRscorewas 10.1 in thebaselinecomparedwith 10.2
in the intervention period. After adjustment, this corre-
sponded to a primary treatment effect (interaction between
treatment group and time period) estimate of −0.03 (95% CI,
−2.58 to 2.52; P = .98) (Table 2). Among patients receiving at
least 2 stress support sessions, the adherence-adjusted causal
effectof the interventiononmeanPSS-SRscorewas−0.18 (95%
CI, −5.50 to 5.14; P = .95).
Of patients surviving to 6 months, 21.2% had missing
PSS-SR score data. Sensitivity analyses, using both complete
case analysis and expert elicitation, had minimal effect on
the primary outcome, reporting treatment effect estimates of
−0.02 (95% CI, −2.52 to 2.47; P = .99) and, combining views
of all experts, −0.59 (95% credible interval, −3.28 to 2.09).
These results were robust to a range of individual expert
opinions (eResults, eFigures 6 and 7, and eTables 18 and 19 in
Supplement 2).
There were no significant differences between groups in
any of the secondary outcomes, either within hospital or at 6
months (Table 2). The proportion of patients with a PSS-SR
score ofmore than 18 points at 6months in intervention ICUs
was 23.9% in the baseline period and 24.1% in the interven-
tion period, compared with 19.8% and 17.6%, respectively, in
control ICUs. After adjustment, this resulted in an odds ratio
of 1.32 (95% CI, 0.66 to 2.67; P = .43). The mean HADS anxi-
ety score at 6months in intervention ICUswas6.9 in thebase-
line period and 6.3 in the intervention period compared with
5.9 and 5.7, respectively, in control ICUs, resulting in an ad-
justed difference in difference of −0.24 (95% CI −1.50 to 1.01;
P = .70). Themean HADS depression score at 6 months in in-
tervention ICUs was 6.0 in the baseline period and 5.8 in the
intervention period compared with 5.3 and 5.3, respectively,
in control ICUs, resulting in an adjusted difference in differ-
ence of −0.22 (95% CI, −1.40 to 0.95; P = .71).
Therewasnosignificant interactionbetween treatmentef-
fect and timeperiodonmeanPSS-SRscores at 6months in any
of the prespecified subgroups (Figure 2).
The incremental netmonetarybenefit comparing thepre-
ventive, complexpsychological interventionvsusual carewas
positive (£835 [US $1188]), but the statistical uncertainty sur-
rounding this resultwas substantial (95%CI, −£4322 to £5992
[US −$6148 to $8523]) (see eResults, eTables 20-26, and
eFigures 8-14 in Supplement 2 for full results of the cost-
effectiveness analysis).
Post Hoc Analysis
For those patientswho received 3 stress support sessions and
had data (91%), post hoc analysis observed a reduction in the
mean STAI-6 score from49.3 at the time of consent to 40.3 at
the end of their third session (eTable 27 in Supplement 2).
Discussion
This trial found that implementation of a nurse-led preven-
tive, complex psychological intervention, initiated in the ICU,
did not significantly reduce PTSD symptom severity at 6
months compared with usual care. There were no statisti-
cally significant differences in any of the prespecified sub-
groups (including degree of implementation of the interven-
tion) or in any of the secondary outcomes (including anxiety,
depression, or HrQoL). Levels of PTSD symptom severity
were in line with previously reported prevalence in this
patient group.
This multicenter, cluster-randomized evaluation of a
preventive, complexpsychological interventionwasdelivered
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alongside routine care in a setting representative of the pro-
posed target population. The complex intervention was
informed, developed, and refined according to Medical
Research Council guidance by experts with considerable
experience in psychology and adult ICUs.12,36 Evidence and
theories of CBT for stress, trauma, hallucinations, paranoid
delusions, and nightmares—adapted for use with ICU
patients—were used. It was designed to be delivered early to
reduce development of longer-term psychological morbid-
ity by alleviating acute stress and frightening ICU memories
both by improving the ICU environment and providing
stress support direct to high-risk patients. It was pragmatic,
from a resource perspective, training ICU-selected nurses to
deliver it.
There are several reasons why the preventive, complex
psychological intervention may not have worked. First,
Table 2. Primary and Secondary Outcomes
Intervention ICUs Control ICUs
Difference
in Differencea P Value
ICC
(95% CI)
Baseline
Period,
Mean
(95% CI)
Intervention
Period,
Mean
(95% CI)
Difference
(95% CI)
Baseline
Period,
Mean
(95% CI)
Intervention
Period,
Mean
(95% CI)
Difference
(95% CI)
Primary Outcome at 6 mob
No. of
patients
245 314 259 415
PSS-SR
symptom
severity
scorec
11.8
(10.3 to 13.3)
11.5
(10.0 to 12.9)
−0.40
(−2.46 to 1.67)
10.1
(8.7 to 11.6)
10.2
(9.1 to 11.3)
0.06
(−1.74 to 1.85)
−0.03
(−2.58 to 2.52)
.98 0.01
(0.00 to 0.40)
Secondary Outcomes
Short-term
No. of
patients
283 340 284 446
Days alive
and free
from
sedation
to day 30
23.0
(22.1 to 23.9)
23.3
(22.4 to 24.1)
0.24
(−0.98 to 1.47)
24.3
(23.6 to 25.0)
24.0
(23.4 to 24.7)
−0.30
(−1.29 to 0.69)
0.47
(−1.03 to 1.96)
.54 0.00
(0.00 to 0.94)
Duration of
ICU stay, d
14.0
(12.1 to 15.8)
14.6
(12.7 to 16.4)
0.61
(−2.02 to 3.23)
12.2
(10.6 to 13.8)
13.5
(12.2 to 14.8)
1.31
(−0.79 to 3.41)
−0.28
(−3.45 to 2.88)
.86 0.00
(0.00 to 0.00)
At 6 mob
No. of
patients
245 314 259 415
PSS-SR
>18 pointsc
23.9
(18.1 to 29.7)d
24.1
(18.8 to 29.4)d
1.01
(0.66 to 1.56)e
19.8
(14.5 to 25.3)d
17.6
(13.6 to 22.0)d
0.87
(0.56 to 1.35)e
1.32
(0.66 to 2.67)f
.43 0.00
(0.00 to 1.00)
HADS
anxiety
scoreg
6.9
(6.2 to 7.6)
6.3
(5.7 to 7.0)
−0.60
(−1.57 to 0.37)
5.9
(5.3 to 6.7)
5.7
(5.2 to 6.2)
−0.26
(−1.13 to 0.62)
−0.24
(−1.50 to 1.01)
.70 0.01
(0.00 to 0.50)
HADS
depression
scoreg
6.0
(5.3 to 6.7)
5.8
(5.1 to 6.4)
−0.28
(−1.21 to 0.65)
5.3
(4.7 to 6.0)
5.3
(4.8 to 5.8)
0.01
(−0.82 to 0.84)
−0.22
(−1.40 to 0.95)
.71 0.00
(0.00 to 1.00)
EQ-5D-5L
utility
scoreh
0.66
(0.62 to 0.70)
0.67
(0.63 to 0.71)
0.01
(−0.05 to 0.06)
0.70
(0.66 to 0.74)
0.69
(0.66 to 0.72)
−0.01
(−0.06 to 0.04)
0.01
(−0.06 to 0.08)
.85 0.02
(0.01 to 0.07)
Abbreviations: EQ-5D-5L, European Quality of Life–5 Dimensions 5-level
questionnaire; HADS, Hospital Anxiety and Depression Scale; ICC, intracluster
correlation; ICU, intensive care unit; ICNARC, Intensive Care National Audit &
Research Centre; MCID, minimal clinically important difference;
PSS-SR, PTSD Symptom Scale–Self-Report.
a Adjusted difference in means (95% CI), unless otherwise indicated. Adjusted
for age, sex, race/ethnicity, deprivation, preexisting anxiety/depression,
planned admission following elective surgery, and ICNARC Physiology Score.
As a post hoc secondary analysis of the primary outcome (clinical
effectiveness), the model was refitted including an additional site-level
covariate of the natural logarithm of the standardizedmortality ratio
(ratio of observed to predicted hospital deaths from the ICNARCH-2015
risk predictionmodel)29 for the period from April 2014 toMarch 2015.
Adjusting for site-level standardizedmortality ratio hadminimal
effect, reporting a treatment effect estimate of −0.14 (95% CI, −2.66
to 2.38; P = .91).
b Reported for patients alive at 6months after applying multiple imputation
to handle missing data.
c PSS-SR scale is from 0 to 51 (higher scores indicate greater posttraumatic
stress symptoms). A value of greater than 18 points is considered the
threshold for prediction of likely current or future PTSD. TheMCID was
considered to be 4.2 points based on observing an improvement equal to the
reliable change index among patients receiving stress support sessions.
d Percentage (95% CI).
e Odds ratio (95% CI).
f Adjusted odds ratio (95% CI).
g HADS comprises 2 subscales (anxiety and depression), both range from0 to 21
(higher scores indicate worse severity). A value of 8 points is considered the
threshold for likely anxiety or depression; the percentages of patients meeting
this threshold across the groups were 40.1%, 38.6%, 35.4%, and 33.7% for
anxiety and 36.7%, 33.1%, 29.9%, and 31.3% for depression for intervention
ICUs in the baseline and intervention periods and control ICUs in the baseline
and intervention periods, respectively. Among survivors of acute respiratory
failure, an MCID of 2.0 to 2.5 has been suggested for the anxiety subscale and
1.9 to 2.3 for the depression subscale.35
h EQ-5D-5L utility scale ranges from −0.285 to 1 (lower scores indicate worse
health-related quality of life). The scale is anchored at 0 (death) and 1 (perfect
health). Health utilities were assigned using the EQ-5D-5L value set for
England.23 Among patients with chronic respiratory disease, anMCID of
around 0.05 has been suggested34; no studies have been conducted to
establish anMCID for patients recovering from critical illness.
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although a recent systematic review has suggested that
addressing risk factors early, initiating it in the ICU, may be
beneficial,37 the timing of the stress support sessions may
have been too early. Perhaps patients are still too ill and
fatigued to focus on (and remember) the therapeutic mes-
sages taught and/or to make best use of the relaxation and
recovery program. In addition, the sessions were based on
therapeutic techniques deemed appropriate for patients in
early recovery (ie, those potentially still enduring the trau-
matic experience), precluding the use of more challenging
Figure 2. Subgroup Analyses of the Primary Clinical Effectiveness Outcome
–10 100 5
Difference in Difference (95% CI)b
–5
P
Value
Favors
Intervention
Favors
Control
Difference From Baseline to Intervention
Period (95% CI)a
Intervention ICUs
ICU Patients, No.
Intervention Control Control ICUsSubgroup
Age, y
Difference in
Difference (95% CI)b
–1.87 (–6.87 to 3.12)118 185 –1.32 (–5.22 to 2.59)18-47 –1.24 (–6.81 to 4.34)
.93
–0.28 (–4.42 to 3.85)141 173 0.20 (-3.45 to 3.85)48-59 0.52 (–4.55 to 5.60)
Sex
–0.61 (–4.00 to 2.77)249 258 –0.27 (–3.32 to 2.78)Female –0.03 (–3.99 to 3.94)
.92
–0.47 (–2.92 to 1.98)310 416 0.12 (–2.01 to 2.25)Male –0.30 (–3.51 to 2.91)
0.22 (–3.48 to 3.92)158 171 0.60 (–2.28 to 3.49)60-69 –0.90 (–5.56 to 3.77)
1.27 (–1.78 to 4.32)142 145 0.27 (–2.43 to 2.97)70-99 0.74 (–4.29 to 5.76)
Index of Multiple
Deprivationc
–0.70 (–5.28 to 3.87)86 143 2.03 (–0.93 to 5.00)1 (least deprived) –2.89 (–8.53 to 2.76)
1.51 (–2.80 to 5.83)128 62 –1.43 (–7.68 to 4.83)0 2.74 (–4.22 to 9.70)
–4.46 (–9.58 to 0.66)112 126 –0.19 (–4.99 to 4.60)5 (most deprived) –3.84 (–9.76 to 2.09)
Duration of delirium, dd
.41–1.54 (–6.00 to 2.92)97 125 –0.46 (–4.48 to 3.56)1-2 –2.31 (–8.28 to 3.67)
–2.46 (–9.35 to 4.44)57 85 2.41 (–2.86 to 7.67)>2 –3.73 (–11.70 to 4.23)
1.55 (–2.09 to 5.19)156 180 0.46 (–2.69 to 3.62)Emergency/urgent 1.17 (–3.53 to 5.87)
Surgical status
.76–1.26 (–7.65 to 5.13)44 75 –0.54 (–5.10 to 4.02)Elective/scheduled –0.90 (–9.36 to 7.57)
–1.26 (–3.87 to 1.35)359 419 0.19 (–2.13 to 2.51)Nonsurgical –0.90 (–4.01 to 2.20)
1.84 (–1.69 to 5.38) 0.06 (–1.73 to 1.84)1 (lowest) 1.46 (–2.30 to 5.22)
Site implementation
score categoryg
.49–0.10 (–3.86 to 3.66) 0.06 (–1.73 to 1.84)2 –0.12 (–3.73 to 3.48)
–2.23 (–5.58 to 1.12) 0.06 (–1.73 to 1.84)3 (highest) –1.23 (–4.70 to 2.25)
1.84 (–2.89 to 6.57)107 152 1.56 (–1.47 to 4.60)2 2.89 (–2.64 to 8.43)
.08–1.34 (–5.31 to 2.64)118 119 –0.07 (–4.18 to 4.05)3 –2.75 (–8.17 to 2.68)
3.79 (–0.27 to 7.84)136 134 –2.76 (–7.03 to 1.50)4 4.99 (–0.31 to 10.28)
STAI-6e
–1.38 (–4.60 to 1.83)151 174 0.92 (–1.95 to 3.78)20-30 –1.01 (–5.75 to 3.74)
.35
–1.22 (–4.80 to 2.37)151 215 1.01 (–2.36 to 4.38)31-43 –1.85 (–6.44 to 2.75)
4.50 (–0.17 to 9.18)116 154 –0.25 (–3.98 to 3.48)44-53 4.25 (–1.15 to 9.64)
–1.52 (–6.06 to 3.02)140 130 –1.50 (–5.63 to 2.63)54-80 –0.11 (–5.31 to 5.10)
Predicted PSS-SR scoref
1.98 (–0.62 to 4.58)119 151 1.74 (–0.89 to 4.36)<7 0.59 (–4.36 to 5.54)
0.61 (–2.94 to 4.16)124 123 –1.74 (–4.96 to 1.48)7-9 1.47 (–3.68 to 6.62)
.08–2.76 (–7.24 to 1.71)100 145 1.76 (–1.75 to 5.27)10-12 –5.48 (–11.18 to 0.22)
3.83 (–0.94 to 8.59)117 153 –0.37 (–4.00 to 3.25)13-15 4.56 (–0.91 to 10.03)
–3.46 (–8.99 to 2.08)98 101 0.07 (–5.53 to 5.67)≥16 –3.87 (–10.52 to 2.79)
ICU indicates intensive care unit; PSS-SR, PTSD Symptom Scale–Self-Report,
and STAI-6, State Trait Anxiety Inventory.
a Mean (95% CI) of the difference between baseline and intervention periods in
mean PSS-SR score. The PSS-SR scale is from 0 to 51 (higher scores indicate
greater posttraumatic stress symptoms). A value of 18 points is considered the
threshold for prediction of likely current or future PTSD. Theminimal clinically
important difference was considered to be 4.2 points based on observing an
improvement equal to the reliable change index among patients receiving
stress support sessions.
bAdjusted for age, sex, race/ethnicity, deprivation, preexisting
anxiety/depression, planned admission following elective surgery, and
Intensive Care National Audit & Research Centre Physiology Score.
c The Index of Multiple Deprivation 2015 is reported by quintiles (higher values
indicate greater deprivation).
dDuration of delirium is reported as the number of days on which patients
were assessed as positive for delirium on the Confusion Assessment Method
for the ICU.
e Scores on the STAI-6 range from 20 to 80 (higher scores indicate greater
anxiety). STAI-6 was self-reported by participants at the time of consent.
f Predicted PSS-SR (heterogeneity of treatment effect) is reported by quintiles
from a predictionmodel for the primary outcome derived using data
from patients receiving usual care and adjusted for a priori important
covariates (age, sex, socioeconomic status, duration of delirium, STAI-6,
and surgical status).
g Site implementation score encompasses dose, fidelity, and reach and is
derived from data collected as part of the independent process evaluation
(see eMethods and eTable 6 in Supplement 2 for more information).
In the intervention ICUs, there were 170, 174, and 215 patients in low, medium,
and high score categories, respectively. In the control ICUs, there were 674
patients receiving usual care.
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techniques such as exposure to traumatic memories (one
element of trauma-focused CBT), and the latter may be
required to reduce PTSD symptom severity.4
Second, 3 sessionswerenotdelivered to all patients. Even
thoughmore than80%ofpatients receivedat least2stress sup-
port sessions, approximately one-third of patients did not re-
ceive session 3. For those patients who received 3 sessions, a
reduction in reported state anxiety was observed. Given the
mainreasonfornot receivingsession3wasdischarge fromhos-
pital, an intervention that follows patients into the commu-
nity may be required.
Third, ICU nurses, as nonexperts, may have struggled to
deliver the sessions as intended. Findings from the process
evaluation indicated that, even though the ICUnurses felt fully
equipped to deliver sessions after training, they found it dif-
ficultwhendealingwithpatientswithcomplexneeds (ie,keep-
ing them on track with the session content). This might have
been enhanced bymore extensive training and greater super-
vision or, potentially, such interventions need to be delivered
by experts.
Fourth, although there was high uptake (>80% of ICU
staff) for the online training intended to promote a thera-
peutic environment in the ICU, difficulties in changing long-
standing practices or with environmental limitations in
some ICUs may have impeded translation into practice.
Other methods of knowledge translation and implementa-
tion may be needed to make substantive changes to the ICU
environment.
Fifth, while the intervention aimed to reduce PTSD
symptom severity by alleviating acute stress and memories
of frightening ICU experiences, other psychological
interventions—for example, to prevent delirium and agita-
tion early in the ICU stay or to alleviate anxiety and/or
depression—may warrant investigation. Further exploratory
analyses of the data could inform future developments
aimed at reducing post-ICU psychological morbidity.
Limitations
This trial has several limitations. First, it was challenging to
deliver,potentiallydue to the typeof intervention (eg, recruit-
ment rate reduced in intervention ICUs during the interven-
tionperiod), as patients reported associating the intervention
with a stigma ofmental illness. Second, it was not possible to
blind patients or staff due to the nature of the intervention,
but contaminationwasavoidedbyusingaclusterdesign,with
geographically diverse ICUs and a short recruitment period.
Third, therewas loss to follow-up for thepatient-reportedpri-
maryoutcome(accounted for in thepowercalculation)butno
difference in responders’ characteristics between treatment
groupand timeperiod.Fourth, the trial designmandated that
the initial approach for consent was in the ICU, as it was as-
sumedthatpatientswould regainmental capacityprior todis-
charge and this did not always occur. Fifth, audio-recording
of a sample of stress support sessions was planned to assess
fidelity. In practice, and likely due to the nature of the inter-
action, the nurses reported that patients found this aspect of
the trial intrusive and felt uncomfortable approaching them
for this. Future studiesmayconsiderusingmoredetailedeth-
nographic methods to assess fidelity.
Conclusions
Among critically ill patients in the ICU, a nurse-led preven-
tive, complex psychological intervention did not signifi-
cantly reduce patient-reported PTSD symptom severity at 6
months. These findingsdonot support theuseof this psycho-
logical intervention.
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